Elias Oluja, a lab technician from Tiriri health centre, tests patients for HIV during his weekly visit to the lab at the Ojom health centre, Katine. Photograph: Dan Chung

Sarah Boseley: A report from the Institute of Health Metrics in Seattle reveals that fears of a total collapse in funding for health in developing countries are unfounded - so far

Refugees queue at the Dadaab camp in Kenya for cooking tools and their first food ration Photograph: Matilde Gattoni

Rajiv Shah, head of USAid, told journalists of a moving encounter with a woman who had been forced to make a desperate choice

Babies rest at the Pouponniere facility in Dakar, Senegal. Photograph: Georges Gobet/AFP/Getty Images

Sarah Boseley: Unwanted babies and unsafe abortion are major problems in the developing world, yet funding for contraception is limited because of attitudes to sex and abortion in donor countries

Shaul Schwarz/Guardian

The Global Fund to fight Aids, TB and Malaria says it is unable to hand out new grants to countries for disease-fighting programmes because of an acute shortage of money, but will support "essential needs"

Cervical cancer is caused by a virus - the human papillomavirus (HPV), above. Photograph: Science photo library

Funding is to be made available for the roll-out of the HPV vaccine to prevent some of the 275,000 cervical cancer deaths in poor countries

Anti-retroviral drugs. Prices have come down dramatically, but Abbott is accused of keeping the cost of its combination treatment Kaletra (not pictured) too high. Image by Krista Kennell/ZUMA/Corbis

Medicines campaigners target Abbott over the high price of its Aids drug, Kaletra. Meanwhile an independent but GAVI-funded study shows the roll-out of pneumococcal vaccine it is supporting is cost-effective

Hillary Clinton has urged the US and other nations to increase their funding for HIV and Aids prevention and treatment. Photograph: Win McNamee/Getty Images

The US secretary of state, Hillary Clinton, has offered to lead the end-stage of the battle against Aids – but will the money be forthcoming to finish the job and deliver an 'Aids-free generation'?

Babies and toddlers are weighed during an immunisation programme at the Ojom health centre, Katine. Photograph: Dan Chung

A series of papers published this week attempts to take a measured look at what happens to the poor, when healthcare fees are abolished in sub-Saharan Africa

Polio vaccination in Bihar, India. Photo: Jean-Marc Giboux

A film from Bihar, one of the most inaccessible areas of India for polio vaccinators, shows how the war on the disease is slowly being won

Sarah Boseley: A hard-hitting report from the UN special rapporteur on health as a human right says all states must provide safe abortion and contraception for women

Margaret Chan, the director general of the WHO, which has been criticised in Rio for its declaration on social determinants of health. Photograph: Fabrice Coffrini/AFP/Getty Images

Sarah Boseley: Health campaigners at WHO Rio conference demand changes that finally acknowledge link between poverty and ill-health

Mary Robinson with Archbishop Desmond Tutu. Photograph: Attila Kisbenedek/AFP/Getty Images

The former Irish president, who has returned to Somalia after 19 years, says humanitarian aid must be linked to education and healthcare, including contraception for women

Dan Chung/Guardian

The first malaria vaccine to get through large trials cuts malaria cases by 56% and severe malaria by 47%. It's only partially effective – but that's no reason for the donors to put their money elsewhere

Ayoreo children in the Chaco region of north-west Paraguay. Photograph: Jorge Adorno/Reuters

Médecins Sans Frontières calls on the Brazilian government to ensure its state-owned drug company steps up production of the only drug for Chagas disease, which affects 10 million people in Latin America

Orphans at the Mildmay HIV Centre in Kampala, Uganda. A funding drop has raised concern about the long-term future of the global fight against HIV and Aids. Photograph: Jon Hrusa/Pool/Reuters

Academics calculate it will cost $14.2bn to keep 3.5 million people well on antiretroviral drugs. But savings from their productivity, ability to bring up children and future medical care could amount to as much as $34bn